Market revenue in 2023 | USD 104.2 million |
Market revenue in 2030 | USD 149.5 million |
Growth rate | 5.3% (CAGR from 2023 to 2030) |
Largest segment | Hemodynamic flow alteration devices |
Fastest growing segment | Plaque Modification Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | PTA Balloons, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Peripheral Accessories, Inferior Vena Cava Filters, Hemodynamic Flow Alteration Devices, Peripheral Stents |
Key market players worldwide | Abbott Laboratories, Edwards Lifesciences Corp, Medtronic PLC, St. Jude Medical, Teleflex Inc, Philips, Boston Scientific Corp, Cook Group, Covidien, AngioScore |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to peripheral vascular devices market will help companies and investors design strategic landscapes.
Hemodynamic flow alteration devices was the largest segment with a revenue share of 18.14% in 2024. Horizon Databook has segmented the Norway peripheral vascular devices market based on pta balloons, catheters, endovascular aneurysm repair stent grafts, plaque modification devices, peripheral accessories, inferior vena cava filters, hemodynamic flow alteration devices, peripheral stents covering the revenue growth of each sub-segment from 2018 to 2030.
The peripheral vascular devices market in Norway is experiencing increased acknowledgment from healthcare professionals and patients, driven by their well-informed awareness of cutting-edge vascular intervention advancements. This awareness not only stimulates market demand but also fuels the development of advanced devices known for their enhanced precision, safety features, and positive patient outcomes.
Moreover, rising elderly population in this region further boosts the industry growth. For instance, as per the data reported in the journal Gerontology revised in September 2023, Norway proudly maintains a relatively modest population of 5.4 million, a figure comparable to other nations.
Concurrently, the demographic makeup reflects an aging population, with 16% of the people aged 67 or above, as of the conclusion of 2021 (Statistics Norway, 2022). Projections indicated a notable escalation in the elderly demographic, forecasting a population surpassing 2 million individuals aged 65 or older by the year 2100.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway peripheral vascular devices market, including forecasts for subscribers. This country databook contains high-level insights into Norway peripheral vascular devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account